Table 1_Integrated multi-omics analysis reveals the mechanisms of naringin in ameliorating high-fat diet-induced metabolic dysfunction-associated steatotic liver disease.doc by Wenping Sun (1465360)

“…Lipidomic analysis revealed that Nar restored hepatic lipid homeostasis, significantly decreasing levels of TGs and diglycerides (DGs), with 20 differentially abundant lipid species identified as potential biomarkers. …”

Table 1_Association between composite dietary antioxidant index and increased urinary albumin excretion: a population-based study.docx by Shaopeng Li (820947)

“…The prevalence of increased ACR decreased across the CDAI quartiles from 13.89% in Q1 to 10.11% in Q4. …”

Demographics and clinical characteristics. by Marin Jacobwitz (22001673)

Comparison between pre-dialysis and dialysis groups regarding clinical features and biological findings. by Arwa Yahyaoui (22683276)

Subjects:

Gene network of significantly enriched KEGG pathway. by Chae Won Lee (14957165)

The impact of MDA on hookworm prevalence and intensity of infection stratified by treatment with IDA or DA. by Jannet A. Tobon Ramos (20855642)

Receiver operating characteristic curve for anti-NIE antibodies for <i>S. stercoralis.</i> by Jannet A. Tobon Ramos (20855642)

“…The seroprevalence did not significantly decrease following DA treatment. These results include all individuals sampled, irrespective of whether they took the medications. …”

Supplementary Material for: Clinical and Experimental Insights into the Role of NETosis in IgA Nephropathy Pathogenesis by figshare admin karger (2628495)

“…Inhibiting NETosis with GSK484 reduced CitH3 levels in IgAN mice and improved clinical outcomes, including decreased proteinuria and increased serum albumin. …”

NIE ELISA results. by Jannet A. Tobon Ramos (20855642)

“…Twelve months post-MDA, hookworm prevalence decreased to 56.5% in DA- and 34.4% in IDA-treated villages, respectively (<i>p</i><0.001, both comparisons). …”

Kato Katz and PCR database 12 months collection. by Jannet A. Tobon Ramos (20855642)

“…Twelve months post-MDA, hookworm prevalence decreased to 56.5% in DA- and 34.4% in IDA-treated villages, respectively (<i>p</i><0.001, both comparisons). …”

Master database baseline, 4 weeks and 1 year. by Jannet A. Tobon Ramos (20855642)

“…Twelve months post-MDA, hookworm prevalence decreased to 56.5% in DA- and 34.4% in IDA-treated villages, respectively (<i>p</i><0.001, both comparisons). …”

Uncertain significance copy number variations found in fetuses by SNP array. by Li Wen (169316)

Subjects:

Description of clinical characteristics of the study population, by gender. by Syed Irfan Karim (10701427)

ELISA analysis revealed a significant decrease in SP (A & B) and CGRP (C & D) protein levels in the corneas and tear fluid of mice treated with 0.5% bupivacaine (BUP) every alternate day for 15 days (administered via subconjunctival injection (SCI) alone or in combination with topical (TOP) application) compared to PBS-treated controls. by Ananya Datta (19932144)

Image 1_A comprehensive analysis of vitamin a deficiency burden and trends: insights from the global burden of disease study 2021 and future predictions to 2050.pdf by Qianhong Hu (22640267)

“…Background<p>Vitamin A deficiency (VAD) continues to pose a significant public health challenge, particularly in low socio-demographic index (SDI) regions, contributing to increased infections, blindness, and child mortality. …”

Table 1_Association between estimated glucose disposal rate and the risk of atherosclerotic cardiovascular disease: insight from cross-sectional and retrospective cohort studies.do... by Zixuan Wang (35190)

“…Background<p>Accumulating data have elucidated a significant association between insulin resistance (IR) and the risk of cardiovascular diseases. …”

Table 1_Association between Life’s Crucial 9 and metabolic dysfunction-associated steatotic liver disease: the mediating role of neutrophil-percentage-to-albumin ratio.docx by Na Zhu (331131)

“…After adjusting for all confounders, LC9 was significantly and negatively associated with both MASLD (OR = 0.59, 95% CI: 0.54–0.64) and hepatic fibrosis (OR = 0.66, 95% CI: 0.45–0.97), with each 10-point increase in the LC9 score decreasing the prevalence by 41% and 34%, respectively. …”

Clinical outcomes of participants challenged with ETEC. by Xueyan Zhang (277449)

Forest plot of CMS clinical score. by Yaqin Wang (188672)

Subjects:

The significantly enriched pathways in the high group compared with the low group. by Bo Zhao (13553)